Oral Cholecystographic Contrast Agents + Betamethasone Sodium Phosphate Betamethasone Acetate Lidocai Interaction
Majorinteraction on record
Description
Renal toxicity reported in patients with liver dysfunction receiving oral cholecystographic agent followed by iodixanol. Postpone iodixanol administration in recent users.
Mechanism
Additive renal toxicity in hepatically impaired patients
Source: NLP:betamethasone sodium phosphate, betamethasone acetate, lidocaine, iodixanol, povidine iodine